Immunovaccine to Present New Pre-clinical Combination Therapy Data at the AACR Annual Meeting
HALIFAX, NOVA SCOTIA–(Marketwired – March 24, 2017) – Immunovaccine Inc. (TSX:IMV)(OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that new […]